Skip to content

Join The Lazy Contractor's Blueprint live on Nov 28 — show up and get 1,000 free Mindy creditsJoin The Lazy Contractor's Blueprint, free and live on Nov 28

Register free
Home/Contractors/Partner Therapeutics, INC./contracts

Federal Contractor Profile

Partner Therapeutics, INC.

$258M obligated·15 awards·2 agencies·4 NAICS
OverviewContractsAgenciesNAICS

Federal Contracts

Showing award actions 1–16 of 16 funded award actions, most recent first.

Contracts with positive obligations
15
Funded award actions shown
16
Obligations shown
$258M
Awarding agencies
2

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of September 15, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Sep 4, 2026Department of Veterans Affairs246-NETWORK CONTRACTING OFFICE 6 (36C246)36C24626N1034325412BIZENGRI MEDICATION$72K
Jun 16, 2026Department of Veterans Affairs246-NETWORK CONTRACTING OFFICE 6 (36C246)36C24626N0782325412EMERG. BIZENGRI MEDS FOR VETERAN$73K
Jun 10, 2026Department of Health and Human ServicesASPR/ORM-SNS75A50323F80027325412LEUKINE 250MCG VIL INJ (5PKG)$34M
May 5, 2026Department of Veterans Affairs246-NETWORK CONTRACTING OFFICE 6 (36C246)36C24626N0690325412EMERGENCY BIZENGRI MEDS. FOR VETERAN$54K
Apr 10, 2026Department of Veterans Affairs246-NETWORK CONTRACTING OFFICE 6 (36C246)36C24626N0637325412EMERGENCY BIZENGRI MEDS FOR VETERAN$36K
Mar 26, 2026Department of Health and Human ServicesASPR/ORM-SNS75A50323F80027325412LEUKINE 250MCG VIL INJ (5PKG)$16M
May 15, 2025Department of Health and Human ServicesASPR/ORM-SNS75A50323F80027325412LEUKINE 250MCG VIL INJ (5PKG)$20M
Nov 6, 2024Department of Health and Human ServicesASPR/ORM-SNS75A50323F80027325412LEUKINE 250MCG VIL INJ (5PKG)$19M
Sep 24, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50124C00061541715PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, EXPLORE LEUKINE EFFICACY, AS WELL AS ADVANCE DEVELOPMENT OF MONOCYTE HUMAN LEUKOCYTE ANTIGEN-DR (MHLA-DR) AS$13M
Aug 5, 2024Department of Health and Human ServicesASPR/ORM-SNS75A50323F80027325412LEUKINE 250MCG VIL INJ (5PKG)$22M
Sep 26, 2023Department of Health and Human ServicesASPR/ORM-SNS75A50323F80027325412LEUKINE 250MCG VIL INJ (5PKG)$22M
Sep 25, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123C00064541714R&D FOR REPURPOSING FX06, A HOST-DIRECTED THERAPY, FOR TREATMENT OF SEVERE DISEASE IN PATIENTS WITH SUDAN VIRUS DISEASE (SVD) OR OTHER FILOVIRUSES AOI #22 REBOOT$748K
Jul 25, 2022Department of Health and Human ServicesASPR/ORM-SNS75A50322F80018325412LEUKINE 250MCG/VIL INJ$59M
Sep 30, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMAHHSO10033003T325414IGF::OT::IGF FOR OTHER FUNCTIONS PROJECT: ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION (RTOR-CSF-0003)$2K
Sep 2, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50121C00080541714PARTNER THERAPEUTICS, INC.: .: BARDA DRIVE : RESEARCH AND DEVELOPMENT OF DIAGNOSTIC TESTS FOR PATIENTS WITH SEPSIS AND IMMUNOPARALYSIS$749K
Sep 16, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50119C00062325412LEUKINE 250MCG/VIL INJ 186,440$55M

Get Alerted Before Partner Therapeutics, INC.'s Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free